Navigation Links
23ème congrès européen sur l'Hypertension et la Protection Cardiovasculaire
Date:6/25/2013

233;té abordée dans l'étude SEVITENSION,[8] dont les premiers résultats ont été présentés lors d'une session de posters dans le cadre du congrès de l'ESH 2013.

L'étude SEVITENSION avait pour objectif de déterminer si l'association fixe olmésartan /amlodipine 40/10 mg pouvait réduire la pression artérielle centrale jusqu'à un niveau similaire à celui obtenu avec l'association du périndopril 8 mg et de l'amlodipine 10 mg, traitement utilisé dans l'étude CAFÉ. Les résultats montrent que non seulement cet objectif a été atteint, mais aussi que la réduction de la pression artérielle centrale était plus importante avec l'association fixe olmésartan /amlodipine 40/10 mg qu'avec l'association du périndopril 8 mg et de l'amlodipine 10 mg. Les autres mesures de la pression artérielle, brachiale conventionnelle ou en ambulatoire sur 24 heures, ont aussi confirmé la supériorité de l'association fixe olmésartan /amlodipine 40/10 mg. Par ailleurs, chez les trois quarts des patients (75,6%) traités avec l'association fixe olmésartan /amlodipine 40/10 mg, la pression artérielle était normalisée et donc inférieure au seuil recommandé par la Société Européenne d'Hypertension pour tous les patients hypertendus (PA<140/90 mmHg).[9] La proportion de patients ayant obtenu ce niveau de pression artérielle avec l'association du périndopril 8 mg et de l'amlodipine 10 mg était presque 20% plus faible (57,5%). "Depuis la publication de l'étude CAFÉ, la référence était l'association du périndopril 8 mg et de l'amlodipine 10 mg, c'est pourquoi nous avons comparé ce traitement de référence avec l'association fixe olm&
'/>"/>

SOURCE Daiichi Sankyo Europe GmbH
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
2. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
3. Global Leaders in Advanced Biofuels Industry Urge Congressional Leaders to Extend Critical Tax Provisions
4. Nation Must Invest in Biomedical Research/Health Workforce, AAHC President Tells Congress
5. PharmAthene Presents Update on SparVax™ rPA Anthrax Vaccine Program at the 2012 World Vaccine Congress
6. Neuralstem CEO to Present at the World Stem Cells and Regenerative Medicine Congress in London
7. ETEX Corporation to present at the 9th World Biomaterial Congress
8. Discovery Labs to Present AFECTAIR® Data at European Congress on Pediatric and Neonatal Ventilation
9. PROLOR Biotech Announces Presentation of Data on Its Long-Acting Clotting Factors at World Federation of Hemophilia World Congress
10. The Legends that Contributed to Silicon Valleys Eminence Assemble for Frost & Sullivans Growth, Innovation and Leadership 2012 Congress
11. BIOCOM Announces Endorsement in 52nd Congressional District Race
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... announced its GHS Label Guide . To align chemical container labeling with ... guide includes explanations of label components, an example of an accurate label, and ...
(Date:7/29/2015)... ... 2015 , ... The third Medical Innovation Impact Index (MI3) Alert considers FDA ... combinations. The current system received a score of 0 (range -10 to +10) for ... of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation and Entrepreneurship. ...
(Date:7/29/2015)... SAINT-MALO, FRANCE (PRWEB) , ... July 29, 2015 ... ... , Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel, a nighttime-specific product ... limits the amount of sugars that are able to enter fat cells, inhibiting ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 2Phytocéane introduces CHRONO NIGHT Express Contouring Bi-Gel 3
... India have demonstrated that producing nanoscopic crystals of a pharmaceutical ... gut even if the drug is not soluble in water. ... drugs being developed by the pharmaceutical industry dissolve only very ... problem for administering such drugs as it means they are ...
... InterMune, Inc. (Nasdaq: ITMN ) today ... rights to danoprevir (also known as RG7227 or ITMN-191) ... for $175 million in cash.  In connection with this ... into in October 2006 has been terminated.  In addition, ...
... SEATTLE, Oct. 6 Glencoe Software, Inc., The ... University Press are pleased to announce the release of ... first scientific image data publication system. First released in ... been under continuous development to support new image data ...
Cached Biology Technology:Nano drugs 2InterMune Sells Danoprevir Rights to Roche for $175 Million 2InterMune Sells Danoprevir Rights to Roche for $175 Million 3InterMune Sells Danoprevir Rights to Roche for $175 Million 4Glencoe Software and The Journal of Cell Biology Pioneer Online Publishing of Scientific Image Data: New Version of JCB DataViewer Released 2Glencoe Software and The Journal of Cell Biology Pioneer Online Publishing of Scientific Image Data: New Version of JCB DataViewer Released 3
(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
(Date:7/13/2015)... SAN JOSE, Calif. , July 13, 2015 ... the leading developer of human interface solutions, today ... second generation touch and display driver integration (TDDI) ... solution is the first to combine Synaptics , ... expertise with proven display driver technology developed in ...
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2
... Honey is the original sweetener, manufactured by honey ... cave paintings depict honey gatherers, as do ancient Egyptian ... been important to nearly every human culture and cuisine. ... chemistry, its history, its unbelievable activity. It,s just an ...
... as environmentally conscious stand-ins for such chemicals as ... air-conditioning systems found in many large buildings. But ... suggests that this diverse class of water-treatment devices ... to flourish in the cooling systems of hospitals, ...
... lapatinib, trastuzumab and paclitaxel significantly improved tumor response rates ... cancers, according to data presented at the 33rd Annual ... Full results were presented at the symposium during a ... CT. Reporters who cannot attend in person ...
Cached Biology News:2 books explore the history and delights of honey, bees and beehives 22 books explore the history and delights of honey, bees and beehives 32 books explore the history and delights of honey, bees and beehives 4Pitt study finds 'green' water treatments may not kill bacteria in large building cooling systems 2Combination therapy reduced HER2-positive breast cancers 2
Standard and modified oligonucleotides up to 150 nt-long at any scale for broad applications. Price starts from 30p/base (10 nmole scale)....
... years of expertise in the field of ... the most powerful systems on the market. ... 000 in-microplate tests requiring incubation and washing ... modules (such as worktable shaker incubators, reader,washer), ...
... Microsphere/Microarray Stabilizer is a is a bovine ... This product is an aqueous solution that ... (phosphate buffered saline), pH 6.6 - 7.2. ... 0.02% methylisothiazolone and 0.02% bromonitrodioxane as a ...
Anti-Phospho-JKK/SEK1/MKK4 pAb Description: 100 g rabbit polyclonal antibody. Reacts with human/mouse/rat. Tested in WB. Research Focus: signal transduction Storage: -20C Shipping Tem...
Biology Products: